background image

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Recruiting
PHASE2

Sponsor:

Michael K. Gibson

Location:

Nashville

Code:

NCT05799144

Conditions

Metastatic Oropharyngeal Carcinoma

Recurrent Oropharyngeal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DNA Vaccine

Human Papillomavirus Tumor Antigen Vaccine

Pembrolizumab

Computed Tomography (CT)

Magnetic Resonance Imaging (MRI)

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients with Advanced Non-small Cell Lung Cancer

Recruiting
PHASE1

Sponsor:

BioNTech SE

Location:

Louisville, Baltimore, Fairfax

Code:

NCT05142189

Conditions

Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BNT116

Cemiplimab

Docetaxel

Carboplatin

Paclitaxel

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Recruiting
PHASE1

Sponsor:

Rush University Medical Center

Location:

Chicago

Code:

NCT06229392

Conditions

Breast Cancer

Breast Cancer Triple Negative

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fluzone Quadrivalent

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Recruiting
PHASE1

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Bethesda

Code:

NCT05968989

Conditions

Influenza

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

VRC-FLUMOS0116-00-VP( FLUMos-v2)

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda

Code:

NCT06253494

Conditions

Endometrial Cancer

Cancer of Endometrium

Carcinoma of Endometrium

Endometrial Carcinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AdHER2DC vaccine

Pembrolizumab

N-803

Lenvatinib

PATHWAY HER2 (4B5) assay

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Recruiting
PHASE2

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Location:

Baltimore

Code:

NCT02451982

Conditions

Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

GVAX pancreatic cancer

Nivolumab

Urelumab

BMS-986253

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Recruiting
PHASE2

Sponsor:

Cellvax Therapeutics Inc

Location:

Chicago, Gahanna, Myrtle Beach

Code:

NCT06636682

Conditions

Prostate Cancer (Adenocarcinoma)

Prostate CA

Prostate Cancers

Prostate Cancer (Post Prostatectomy)

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

FK-PC101

Standard of Care (SOC)

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Recruiting
PHASE2

Sponsor:

Mayo Clinic

Location:

Scottsdale, Jacksonville, Rochester

Code:

NCT06639074

Conditions

Advanced Fallopian Tube Carcinoma

Advanced Fallopian Tube High Grade Serous Adenocarcinoma

Advanced Ovarian Carcinoma

Advanced Ovarian Carcinosarcoma

Advanced Ovarian Clear Cell Adenocarcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

Leukapheresis

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

Recruiting

Sponsor:

Emory University

Location:

Atlanta

Code:

NCT03501576

Conditions

Chronic Lymphocytic Leukemia

Diffuse Large B-Cell Lymphoma

Follicular Lymphoma

Mantle Cell Lymphoma

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Inactivated Influenza Vaccine

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Recruiting

Sponsor:

Yale University

Location:

New Haven

Code:

NCT06172660

Conditions

RSV Infection

Eligibility Criteria

Sex: All

Age: 0 - 12

Healthy Volunteers: Not accepted

Interventions

Nirsevimab

What are vaccine clinical trials?

Types of interventions studied in vaccine clinical trials

Eligibility and participation in vaccine clinical trials

How to enroll in a vaccine clinical trial